E. Mancuso

Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?

M. Inglese, A. Laroni, N. Bruschi, 2021, Journal of the Neurological Sciences.

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors

K. Fischer, R. Klamroth, A. Gringeri, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis

M. Inglese, G. Mancardi, A. Uccelli, 2021, Neurotherapeutics.

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

J. Oldenburg, V. Jiménez‐Yuste, C. Kempton, 2018, The New England journal of medicine.

Orthopaedic management of haemophilia arthropathy of the ankle

K. Mulder, A. Forsyth, S. Mortazavi, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

What happens after fingolimod discontinuation? A multicentre real-life experience

G. Marfia, D. Landi, M. Inglese, 2021, Journal of Neurology.

Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities

M. Inglese, L. Roccatagliata, A. Signori, 2023, Frontiers in Neurology.